Literature DB >> 25783561

Variations in albumin use in patients with cirrhosis: An AASLD members survey.

Jasmohan S Bajaj1, Jacqueline G O'Leary2, Florence Wong3, Patrick S Kamath4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25783561     DOI： 10.1002/hep.27789

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease.

Authors:  Manuel Tufoni; Maurizio Baldassarre; Giacomo Zaccherini; Agnese Antognoli; Paolo Caraceni
Journal:  Curr Hepatol Rep       Date:  2020-07-01

2.  Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial.

Authors:  Louise China; Simon S Skene; Zainib Shabir; Alexander Maini; Yvonne Sylvestre; Kate Bennett; Scott Bevan; James O'Beirne; Ewan Forrest; Jim Portal; Steve Ryder; Gavin Wright; Derek W Gilroy; Alastair O'Brien
Journal:  Clin Gastroenterol Hepatol       Date:  2017-09-12       Impact factor: 11.382

3.  The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain.

Authors:  M Chris Runken; Paolo Caraceni; Javier Fernandez; Alexander Zipprich; Rashad Carlton; Martin Bunke
Journal:  Health Econ Rev       Date:  2019-07-05

4.  Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis.

Authors:  Zhaohui Bai; Mauro Bernardi; Eric M Yoshida; Hongyu Li; Xiaozhong Guo; Nahum Méndez-Sánchez; Yingying Li; Ran Wang; Jiao Deng; Xingshun Qi
Journal:  Aging (Albany NY)       Date:  2019-10-08       Impact factor: 5.682
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.